HER2-positive Breast Cancer Registry

Part of paid clinical trials in Overland Park, Kansas.

Sponsor
Priyanka Sharma
Study ID
NCT06603597
Status
Recruiting
Apply to this trial

Conditions

  • HER2 + Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Key Dates

Start date
Sep 27, 2024
Status verified
Sep 2025
Primary completion
Oct 31, 2044
Completion
Oct 31, 2044

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: HER2-positive breast cancer
    Patients with stage I-IV HER2-positive breast cancer

Primary Outcome Measure

Overall survival rate [ Time Frame: From diagnosis to 5 years after diagnosis ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
KUCC - Indian CreekOverland ParkKansas66211-
KUCC - Overland ParkOverland ParkKansas66215-
KUCC - BriarcliffWestwoodKansas66205-
KUCC - OlatheWestwoodKansas66205-
The University of Kansas Cancer CenterWestwoodKansas66205
Study Coordinator
[email protected]
913-588-6079
KUCC - Lee's SummitLee's SummitMissouri64064-

Find similar trials in Overland Park, KS

By research site
KUCC - Indian Creek· Overland Park, KSKUCC - Overland Park· Overland Park, KSKUCC - Briarcliff· Westwood, KSKUCC - Olathe· Westwood, KSThe University of Kansas Cancer Center· Westwood, KSKUCC - Lee's Summit· Lee's Summit, MO

Related Studies